Search
for
Sort by
Research 841–870 of 969
- Alopecia Areata in Latin America: Where are We and Where are We Going?
- Review of robotic surgery platforms and end effectors
- Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients
- Coronavirus Infection and Cholesterol Metabolism
- COVID‐19 and cutaneous manifestations: A review of the published literature
- Male reproductive health after 3 months from SARS-CoV-2 infection: a multicentric study
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees
- Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis
- SARS-CoV-2-induced Host Metabolic Reprogram (HMR): Nutritional Interventions for Global Management of COVID-19 and Post-Acute Sequelae of COVID-19 (PASC)
- Reply to the Letter to the Editor “Androgen deprivation therapy may constitute a more effective prophylactic than therapeutic strategy in COVID-19 patients” by N. Bennani and I. M. Bennani-Baiti
- Correlation between Androgenetic Alopecia and Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection in China
- O papel dos andrógenos na alopecia androgenética associada à gravidade do COVID-19
- Dermatological Manifestations of Patients with COVID 19: A Cross-sectional study
- Beyond health-related quality of life: initial psychometric validation of a new scale for addressing the gap in assessing the full range of alopecia areata psychosocial burden
- The JAK/STAT signaling pathway: from bench to clinic
- Pathological sequelae of long-haul COVID
- Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study
- Systematic Review: Allogenic Use of Stromal Vascular Fraction (SVF) and Decellularized Extracellular Matrices (ECM) as Advanced Therapy Medicinal Products (ATMP) in Tissue Regeneration
- Immunomodulatory properties of mesenchymal stromal/stem cells: The link with metabolism
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Targeting integrin pathways: mechanisms and advances in therapy
- Mesenchymal Stem Cell-Derived Extracellular Vesicles for Therapeutic Use and in Bioengineering Applications
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
- Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
- Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods